As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
The global cytokine market is expected to grow in the forecast period of 2021-2026 at a CAGR of 6%.
Cytokines are known to play an essential role in many disease processes; they can be used in treating many disorders. An individual’s ability to fight off infection can be determined by measuring cytokine production. Cytokine are used as therapeutic agents in treating people with cancer and immunodeficiency disorders and those undergoing organ transplantation. Cytokine can enhance the vaccines’ effectiveness when mixed with a vaccine. They also act as fighting agents in our bodies. When they are released, they signal the immune system to do its job. Cytokine affects the growth of all blood cells and other cells that help the body's immune and inflammation responses. They also help boost anti-cancer activity in the body by sending signals that can help make abnormal cells die and normal cells live longer. The increasing prevalence of diseases like cancer and skin disorders is expected to drive the growth of the cytokine industry.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Cytokine refers to a group of small, short-lived proteins that are released by one cell to regulate the function of another cell, thereby serving as intercellular chemical messengers. Cytokine effect changes in cellular behaviour that are important in a number of physiological processes, including reproduction, growth and development, and injury repair.
Based on type, the market is divided into:
Based on therapeutic application, the market is divided into:
The EMR report looks into the regional markets of cytokine like North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.
Cytokine has proven to be effective in the treatment of cancer and may continue to play a major role in the development of cancer immunotherapy. Cloned cytokine has been used for the treatment of hepatitis C, hepatitis B, and many types of cancer. Cytokine is also effective for the treatment of a rare hereditary disease. Further, cytokines, when released in response to inflammation, infection, and immunity, can help restrict the growth of cancer. The therapeutic application of cytokine in the treatment of cancer is expected to hold the largest share of the market. This could be attributed to the increasing acceptance of cytokine in cancer therapy over the world. Moreover, the cytokine is generally used in R&D activities in the field of drug development and life sciences. The growing demand for cytokine for wound management and cancer therapeutics is expected to drive the growth of the market. The cytokine industry is anticipated to grow over the forecast period owing to the advancement of new technologies.
The report presents a detailed analysis of the following key players in the global cytokine market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
|Scope of the Report||Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Therapeutic Application, Regions|
|Breakup by Type||Tumour Necrosis Factor - TNF, Interleukins - II, Interferons - IFN, Epidermal Growth Factor - EGF, Others|
|Breakup by Therapeutic Application||Cancer, Asthma and Airway Inflammation, Arthritis, Others|
|Breakup by Regions||North America, Europe, Asia Pacific, Latin America, Middle East and Africa|
|Market Dynamics||SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand|
|Competitive Landscape||Market Structure, Company Profiles-Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications|
|Companies Covered||F. Hoffmann-La Roche Ltd, Merck KGaA, Lonza Group Ltd, Abcam plc., Genscript Biotech Corporation, Randox Laboratories Ltd., Others|
|Report Price and Purchase Option||Explore our purchase options that are best suited to your resources and industry needs.|
|Delivery Format||Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.|
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
7 Industry Opportunities and Challenges
8 Global Cytokine Market Analysis
8.1 Key Industry Highlights
8.2 Global Cytokine Historical Market (2016-2020)
8.3 Global Cytokine Market Forecast (2021-2026)
8.4 Global Cytokine Market by Type
8.4.1 Tumour Necrosis Factor - TNF
184.108.40.206 Market Share
220.127.116.11 Historical Trend (2016-2020)
18.104.22.168 Forecast Trend (2021-2026)
8.4.2 Interleukins - II
22.214.171.124 Market Share
126.96.36.199 Historical Trend (2016-2020)
188.8.131.52 Forecast Trend (2021-2026)
8.4.3 Interferons - IFN
184.108.40.206 Market Share
220.127.116.11 Historical Trend (2016-2020)
18.104.22.168 Forecast Trend (2021-2026)
8.4.4 Epidermal Growth Factor - EGF
22.214.171.124 Market Share
126.96.36.199 Historical Trend (2016-2020)
188.8.131.52 Forecast Trend (2021-2026)
8.5 Global Cytokine Market by Therapeutic Application
184.108.40.206 Market Share
220.127.116.11 Historical Trend (2016-2020)
18.104.22.168 Forecast Trend (2021-2026)
8.5.2 Asthma and Airway Inflammation
22.214.171.124 Market Share
126.96.36.199 Historical Trend (2016-2020)
188.8.131.52 Forecast Trend (2021-2026)
184.108.40.206 Market Share
220.127.116.11 Historical Trend (2016-2020)
18.104.22.168 Forecast Trend (2021-2026)
8.6 Global Cytokine Market by Region
8.6.1 Market Share
22.214.171.124 North America
126.96.36.199 Asia Pacific
188.8.131.52 Latin America
184.108.40.206 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
220.127.116.11 United States of America
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country
18.104.22.168 United Kingdom
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
22.214.171.124 Saudi Arabia
126.96.36.199 United Arab Emirates
188.8.131.52 South Africa
10 Market Dynamics
10.1 SWOT Analysis
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 F. Hoffmann-La Roche Ltd
184.108.40.206 Company Overview
220.127.116.11 Product Portfolio
18.104.22.168 Demographic Reach and Achievements
11.2.2 Merck KGaA
22.214.171.124 Company Overview
126.96.36.199 Product Portfolio
188.8.131.52 Demographic Reach and Achievements
11.2.3 Lonza Group Ltd
184.108.40.206 Company Overview
220.127.116.11 Product Portfolio
18.104.22.168 Demographic Reach and Achievements
11.2.4 Abcam plc.
22.214.171.124 Company Overview
126.96.36.199 Product Portfolio
188.8.131.52 Demographic Reach and Achievements
11.2.5 Genscript Biotech Corporation
184.108.40.206 Company Overview
220.127.116.11 Product Portfolio
18.104.22.168 Demographic Reach and Achievements
11.2.6 Randox Laboratories Ltd.
22.214.171.124 Company Overview
126.96.36.199 Product Portfolio
188.8.131.52 Demographic Reach and Achievements
12 Industry Events and Developments
List of Figures and Tables
1. Global Cytokine Market: Key Industry Highlights, 2016 and 2026
2. Global Cytokine Historical Market: Breakup by Type (USD Million), 2016-2020
3. Global Cytokine Market Forecast: Breakup by Type (USD Million), 2021-2026
4. Global Cytokine Historical Market: Breakup by Therapeutic Application (USD Million), 2016-2020
5. Global Cytokine Market Forecast: Breakup by Therapeutic Application (USD Million), 2021-2026
6. Global Cytokine Historical Market: Breakup by Region (USD Million), 2016-2020
7. Global Cytokine Market Forecast: Breakup by Region (USD Million), 2021-2026
8. North America Cytokine Historical Market: Breakup by Country (USD Million), 2016-2020
9. North America Cytokine Market Forecast: Breakup by Country (USD Million), 2021-2026
10. Europe Cytokine Historical Market: Breakup by Country (USD Million), 2016-2020
11. Europe Cytokine Market Forecast: Breakup by Country (USD Million), 2021-2026
12. Asia Pacific Cytokine Historical Market: Breakup by Country (USD Million), 2016-2020
13. Asia Pacific Cytokine Market Forecast: Breakup by Country (USD Million), 2021-2026
14. Latin America Cytokine Historical Market: Breakup by Country (USD Million), 2016-2020
15. Latin America Cytokine Market Forecast: Breakup by Country (USD Million), 2021-2026
16. Middle East and Africa Cytokine Historical Market: Breakup by Country (USD Million), 2016-2020
17. Middle East and Africa Cytokine Market Forecast: Breakup by Country (USD Million), 2021-2026
18. Global Cytokine Market Structure
The global cytokine market is projected to grow at a CAGR of 6% between 2021 and 2026.
The market is driven by the increasing prevalence of diseases such as cancer and skin disorders, growing demand for cytokine for wound management and cancer therapeutics and increasing disposable income.
The market is expected to be defined by the technological advancements in the industry.
The major regions in the industry are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The different type of cytokine available in the market are tumour necrosis factor – TNF, Interleukins – II, Interferons – IFN, and epidermal growth factor - EGF, among others.
The various therapeutic applications of cytokine is in diseases, such as cancer, asthma and airway inflammation, and arthritis, among others.
The leading players in this market are F. Hoffmann-La Roche Ltd., Merck KGaA, Lonza Group Ltd., Abcam plc, Genscript Biotech Corporation, and Randox Laboratories Ltd., among others.
The global cytokine market is driven by increasing prevalence of diseases, such as cancer and skin disorders. Aided by the technological advances in the industry, the market is expected to witness a further a growth in the forecast period of 2021-2026, growing at a CAGR of 6%.
EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. The cytokine industry is divided on the basis of types into tumour necrosis factor – TNF, Interleukins – II, Interferons – IFN, and epidermal growth factor - EGF, among others. The market is segmented on the basis of therapeutic applications into cancer, asthma and airway inflammation, and arthritis, among others. The key players in the above industry include F. Hoffmann-La Roche Ltd., Merck KGaA, Lonza Group Ltd., Abcam plc, Genscript Biotech Corporation, and Randox Laboratories Ltd., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.